{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:36:19Z","timestamp":1782398179659,"version":"3.54.5"},"reference-count":129,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clp.2019.02.011","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T08:29:13Z","timestamp":1553934553000},"page":"291-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia"],"prefix":"10.1016","volume":"46","author":[{"given":"Erica W.","family":"Mandell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Kratimenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Abman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin H.","family":"Steinhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2019.02.011_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM196702162760701","article-title":"Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia","volume":"276","author":"Northway","year":"1967","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.011_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012","volume":"314","author":"Stoll","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2019.02.011_bib3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia","volume":"163","author":"Jobe","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clp.2019.02.011_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1203\/00006450-199912000-00007","article-title":"The new BPD: an arrest of lung development","volume":"46","author":"Jobe","year":"1999","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clp.2019.02.011_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0046-8177(98)90280-5","article-title":"Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia","volume":"29","author":"Husain","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clp.2019.02.011_bib6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1164\/ajrccm.160.4.9810071","article-title":"Neonatal chronic lung disease in extremely immature baboons","volume":"160","author":"Coalson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clp.2019.02.011_bib7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jpeds.2015.07.067","article-title":"Prediction of late death or disability at age 5 years using a count of 3 neonatal morbidities in very low birth weight infants","volume":"167","author":"Schmidt","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1164\/rccm.201612-2414OC","article-title":"Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants","volume":"196","author":"Morrow","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clp.2019.02.011_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2017.04.026","article-title":"Bronchopulmonary dysplasia and perinatal characteristics predict 1-year respiratory outcomes in newborns born at extremely low gestational age: a prospective cohort study","volume":"187","author":"Keller","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpeds.2017.08.006","article-title":"Chronic pulmonary insufficiency of prematurity: developing optimal endpoints for drug development","volume":"191","author":"Steinhorn","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib11","doi-asserted-by":"crossref","first-page":"e154577","DOI":"10.1001\/jamapediatrics.2015.4577","article-title":"Prenatal and perinatal determinants of lung health and disease in early life: a national heart, lung, and blood institute workshop report","volume":"170","author":"Manuck","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.placenta.2014.05.003","article-title":"Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension","volume":"35","author":"Mestan","year":"2014","journal-title":"Placenta"},{"issue":"Suppl 3","key":"10.1016\/j.clp.2019.02.011_bib13","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1513\/AnnalsATS.201312-424LD","article-title":"Bronchopulmonary dysplasia: NHLBI workshop on the primary prevention of chronic lung diseases","volume":"11","author":"McEvoy","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.clp.2019.02.011_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1164\/rccm.201412-2142PP","article-title":"Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia","volume":"192","author":"Islam","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clp.2019.02.011_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpeds.2010.02.006","article-title":"Scope and impact of early and late preterm infants admitted to the PICU with respiratory illness","volume":"157","author":"Gunville","year":"2010","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jpeds.2017.08.005","article-title":"Can we prevent bronchopulmonary dysplasia?","volume":"189","author":"Aschner","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.201611-2386ED","article-title":"The evolution of bronchopulmonary dysplasia after 50 years","volume":"195","author":"Abman","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clp.2019.02.011_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fimmu.2014.00584","article-title":"Strategies to prevent preterm birth","volume":"5","author":"Newnham","year":"2014","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.clp.2019.02.011_bib19","article-title":"Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.011_bib20","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/AOG.0b013e3182723b1b","article-title":"Practice bulletin no. 130: prediction and prevention of preterm birth","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2019.02.011_bib21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.15585\/mmwr.mm6543a1","article-title":"Effects of maternal age and age-specific preterm birth rates on overall preterm birth rates - United States, 2007 and 2014","volume":"65","author":"Ferre","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2019.02.011_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.1995.03520290065031","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2019.02.011_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1990.tb01711.x","article-title":"The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials","volume":"97","author":"Crowley","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.clp.2019.02.011_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1542\/peds.86.3.331","article-title":"Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia","volume":"86","author":"Van Marter","year":"1990","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.clp.2019.02.011_bib25","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.011_bib26","doi-asserted-by":"crossref","first-page":"e180761","DOI":"10.1001\/jamapediatrics.2018.0761","article-title":"Association of early inhaled nitric oxide with the survival of preterm neonates with pulmonary hypoplasia","volume":"172","author":"Ellsworth","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"4","key":"10.1016\/j.clp.2019.02.011_bib27","article-title":"Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants","author":"Askie","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.011_bib28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/apa.12656","article-title":"Systematic review and meta-analysis of optimal initial fraction of oxygen levels in the delivery room at <\/=32\u00a0weeks","volume":"103","author":"Saugstad","year":"2014","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamapediatrics.2015.3794","article-title":"Association of oxygen target and growth status with increased mortality in small for gestational age infants: further analysis of the surfactant, positive pressure and pulse oximetry randomized trial","volume":"170","author":"Walsh","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib30","first-page":"L517","article-title":"The lungs and vitamin A","volume":"262","author":"Chytil","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.clp.2019.02.011_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-3476(05)81793-7","article-title":"Vitamin A supplementation and bronchopulmonary dysplasia\u2013revisited","volume":"121","author":"Shenai","year":"1992","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.clp.2019.02.011_bib32","article-title":"Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants","author":"Darlow","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.011_bib33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jpeds.2013.11.040","article-title":"Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure","volume":"164","author":"Gadhia","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib34","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.011_bib35","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.011_bib36","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1183\/09031936.00012412","article-title":"Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine","volume":"41","author":"Weichelt","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clp.2019.02.011_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2013.09.026","article-title":"Caffeine protects neuronal cells against injury caused by hyperoxia in the immature brain","volume":"67","author":"Endesfelder","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clp.2019.02.011_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ppul.1950060112","article-title":"Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasia","volume":"6","author":"Davis","year":"1989","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clp.2019.02.011_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000442937","article-title":"Caffeine prevents hyperoxia-induced functional and structural lung damage in preterm rabbits","volume":"109","author":"Nagatomo","year":"2016","journal-title":"Neonatology"},{"key":"10.1016\/j.clp.2019.02.011_bib40","doi-asserted-by":"crossref","first-page":"e97357","DOI":"10.1371\/journal.pone.0097357","article-title":"Caffeine and rolipram affect Smad signalling and TGF-beta1 stimulated CTGF and transgelin expression in lung epithelial cells","volume":"9","author":"Fehrholz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clp.2019.02.011_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/dvdy.21403","article-title":"TGF-beta signaling is dynamically regulated during the alveolarization of rodent and human lungs","volume":"237","author":"Alejandre-Alcazar","year":"2008","journal-title":"Dev Dyn"},{"key":"10.1016\/j.clp.2019.02.011_bib42","doi-asserted-by":"crossref","first-page":"e0200661","DOI":"10.1371\/journal.pone.0200661","article-title":"Effect of progesterone on Smad signaling and TGF-beta\/Smad-regulated genes in lung epithelial cells","volume":"13","author":"Kunzmann","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clp.2019.02.011_bib43","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3109\/14767058.2014.885941","article-title":"Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants","volume":"27","author":"Taha","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.clp.2019.02.011_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/bcp.13089","article-title":"Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates","volume":"83","author":"Kua","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clp.2019.02.011_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jpeds.2018.01.010","article-title":"Early caffeine and weaning from mechanical ventilation in preterm infants: a randomized, placebo-controlled trial","volume":"196","author":"Amaro","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib46","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jpeds.2014.01.054","article-title":"Timing of caffeine therapy in very low birth weight infants","volume":"164","author":"Schmidt","year":"2014","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2019.02.011_bib47","article-title":"Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants","author":"Onland","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.clp.2019.02.011_bib48","article-title":"Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants","author":"Shah","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.clp.2019.02.011_bib49","article-title":"Late (>\/= 7\u00a0days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants","author":"Onland","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.clp.2019.02.011_bib50","article-title":"Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants","author":"Ng","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.011_bib51","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1164\/rccm.201101-0055OC","article-title":"Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants","volume":"183","author":"Laughon","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clp.2019.02.011_bib52","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jpeds.2014.07.049","article-title":"An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia","volume":"165","author":"Doyle","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib53","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.siny.2017.07.003","article-title":"Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - who might benefit?","volume":"22","author":"Doyle","year":"2017","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.clp.2019.02.011_bib54","article-title":"Early (< 8\u00a0days) postnatal corticosteroids for preventing chronic lung disease in preterm infants","author":"Halliday","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.011_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000279992","article-title":"Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"issue":"1","key":"10.1016\/j.clp.2019.02.011_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001146.pub3","article-title":"Early (< 8\u00a0days) postnatal corticosteroids for preventing chronic lung disease in preterm infants","author":"Halliday","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.011_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1542\/peds.107.2.217","article-title":"Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease","volume":"107","author":"Murphy","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.011_bib58","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa032089","article-title":"Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity","volume":"350","author":"Yeh","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.011_bib59","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1542\/peds.2004-1238","article-title":"Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease","volume":"115","author":"Doyle","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.011_bib60","first-page":"267","article-title":"Hedgehog signaling has a protective effect in glucocorticoid-induced mouse neonatal brain injury through an 11betaHSD2-dependent mechanism","volume":"119","author":"Heine","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clp.2019.02.011_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clp.2013.09.006","article-title":"Steroids and injury to the developing brain: net harm or net benefit?","volume":"41","author":"Malaeb","year":"2014","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.clp.2019.02.011_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1542\/peds.2004-2843","article-title":"Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial","volume":"117","author":"Doyle","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.011_bib63","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.2017.2692","article-title":"Association between early low-dose hydrocortisone therapy in extremely preterm neonates and neurodevelopmental outcomes at 2 years of age","volume":"317","author":"Baud","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2019.02.011_bib64","article-title":"Effect of prophylaxis of early adrenal insufficiency using low-dose hydrocortisone in very preterm infants: an individual patient data meta-analysis","author":"Shaffer","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib65","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13063-018-2505-y","article-title":"Systemic Hydrocortisone to Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan","volume":"19","author":"Onland","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.clp.2019.02.011_bib66","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000316978","article-title":"Survey of practices regarding utilization of inhaled steroids in 223 German neonatal units","volume":"98","author":"Maas","year":"2010","journal-title":"Neonatology"},{"key":"10.1016\/j.clp.2019.02.011_bib67","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1080\/14767058.2017.1350644","article-title":"Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates","volume":"31","author":"Kelly","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.clp.2019.02.011_bib68","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1501917","article-title":"Early inhaled budesonide for the prevention of bronchopulmonary dysplasia","volume":"373","author":"Bassler","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.011_bib69","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa1708831","article-title":"Long-term effects of inhaled budesonide for bronchopulmonary dysplasia","volume":"378","author":"Bassler","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.011_bib70","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.1542\/peds.2007-1973","article-title":"Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study","volume":"121","author":"Yeh","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.011_bib71","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","article-title":"Intratracheal administration of budesonide\/surfactant to prevent bronchopulmonary dysplasia","volume":"193","author":"Yeh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clp.2019.02.011_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12890-017-0550-z","article-title":"Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.clp.2019.02.011_bib73","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2511","article-title":"Inhaled corticosteroids for bronchopulmonary dysplasia: a meta-analysis","volume":"138","author":"Shinwell","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.clp.2019.02.011_bib74","article-title":"Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates","author":"Shah","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.011_bib75","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/jp.2014.141","article-title":"Inhaled bronchodilator use for infants with bronchopulmonary dysplasia","volume":"35","author":"Slaughter","year":"2015","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.clp.2019.02.011_bib76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ppul.10424","article-title":"Pulmonary function in bronchopulmonary dysplasia","volume":"37","author":"Robin","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clp.2019.02.011_bib77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s004310050771","article-title":"Response to bronchodilators in clinically stable 1-year-old patients with bronchopulmonary dysplasia","volume":"157","author":"De Boeck","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib78","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1164\/ajrccm\/142.5.1137","article-title":"Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia","volume":"142","author":"Brundage","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.clp.2019.02.011_bib79","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jpeds.2005.06.039","article-title":"Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants","volume":"147","author":"Oh","year":"2005","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clp.2011.12.007","article-title":"Neonatal diuretic therapy: furosemide, thiazides, and spironolactone","volume":"39","author":"Segar","year":"2012","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.clp.2019.02.011_bib81","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.siny.2017.08.002","article-title":"Bronchopulmonary dysplasia: Myths of pharmacologic management","volume":"22","author":"Donn","year":"2017","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.clp.2019.02.011_bib82","article-title":"Furosemide exposure and prevention of bronchopulmonary dysplasia in premature infants","author":"Greenberg","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib83","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpeds.2018.01.066","article-title":"Acute responses to diuretic therapy in extremely low gestational age newborns: results from the prematurity and respiratory outcomes program cohort study","volume":"197","author":"Blaisdell","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib84","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJM198303313081303","article-title":"Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome","volume":"308","author":"Green","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2019.02.011_bib85","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1203\/PDR.0b013e3181c2df30","article-title":"In\u00a0vivo dilatation of the ductus arteriosus induced by furosemide in the rat","volume":"67","author":"Toyoshima","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clp.2019.02.011_bib86","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpeds.2018.03.067","article-title":"Association between furosemide exposure and patent ductus arteriosus in hospitalized infants of very low birth weight","volume":"199","author":"Thompson","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib87","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0022-3476(05)81373-3","article-title":"Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia","volume":"124","author":"Kao","year":"1994","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib88","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1055\/s-0035-1547326","article-title":"Point prevalence, clinical characteristics, and treatment variation for infants with severe bronchopulmonary dysplasia","volume":"32","author":"Guaman","year":"2015","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.clp.2019.02.011_bib89","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1164\/rccm.201409-1594OC","article-title":"Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia","volume":"191","author":"Mourani","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clp.2019.02.011_bib90","article-title":"Early pulmonary vascular disease in preterm infants is associated with late respiratory outcomes in childhood","author":"Mourani","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clp.2019.02.011_bib91","doi-asserted-by":"crossref","first-page":"L600","DOI":"10.1152\/ajplung.2000.279.3.L600","article-title":"Inhibition of angiogenesis decreases alveolarization in the developing rat lung","volume":"279","author":"Jakkula","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.clp.2019.02.011_bib92","doi-asserted-by":"crossref","first-page":"L749","DOI":"10.1152\/ajplung.00334.2002","article-title":"Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease","volume":"284","author":"Afshar","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.clp.2019.02.011_bib93","doi-asserted-by":"crossref","first-page":"L1271","DOI":"10.1152\/ajplung.00224.2007","article-title":"Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition","volume":"293","author":"Tang","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.clp.2019.02.011_bib94","doi-asserted-by":"crossref","first-page":"L119","DOI":"10.1152\/ajplung.00395.2005","article-title":"Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia","volume":"291","author":"Balasubramaniam","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.clp.2019.02.011_bib95","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1542\/peds.2010-3428","article-title":"Inhaled nitric oxide in preterm infants: a systematic review","volume":"127","author":"Donohue","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.011_bib96","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1542\/peds.2010-2725","article-title":"Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials","volume":"128","author":"Askie","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.011_bib97","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.clp.2019.02.011_bib98","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpeds.2015.11.050","article-title":"Recommendations for the use of inhaled nitric oxide therapy in premature newborns with severe pulmonary hypertension","volume":"170","author":"Kinsella","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib99","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1542\/peds.2010-3507","article-title":"NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants","volume":"127","author":"Cole","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.011_bib100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2017.10.004","article-title":"Race effects of inhaled nitric oxide in preterm infants: an individual participant data meta-analysis","volume":"193","author":"Askie","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib101","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.clp.2015.08.010","article-title":"Pulmonary hypertension and vascular abnormalities in bronchopulmonary dysplasia","volume":"42","author":"Mourani","year":"2015","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.clp.2019.02.011_bib102","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/ppe.12444","article-title":"Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta-analysis","volume":"32","author":"Arjaans","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.clp.2019.02.011_bib103","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2017.05.029","article-title":"Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia","volume":"188","author":"Krishnan","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib104","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1164\/rccm.200310-1483OC","article-title":"Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia","volume":"170","author":"Mourani","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 2","key":"10.1016\/j.clp.2019.02.011_bib105","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/jp.2016.44","article-title":"Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates","volume":"36","author":"Lakshminrusimha","year":"2016","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.clp.2019.02.011_bib106","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000444895","article-title":"Advances in neonatal pulmonary hypertension","volume":"109","author":"Steinhorn","year":"2016","journal-title":"Neonatology"},{"key":"10.1016\/j.clp.2019.02.011_bib107","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1465-9921-10-30","article-title":"Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury","volume":"10","author":"de Visser","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.clp.2019.02.011_bib108","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpeds.2008.09.021","article-title":"Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease","volume":"154","author":"Mourani","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib109","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/jp.2011.131","article-title":"Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?","volume":"32","author":"Nyp","year":"2012","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.clp.2019.02.011_bib110","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/archdischild-2012-303333","article-title":"The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia","volume":"98","author":"Wardle","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clp.2019.02.011_bib111","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.113.005698","article-title":"STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension","volume":"129","author":"Barst","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.clp.2019.02.011_bib112","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/rccm.201210-1928PP","article-title":"Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension","volume":"187","author":"Abman","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clp.2019.02.011_bib113","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1542\/hpeds.2015-0076","article-title":"Sildenafil treatment of infants with bronchopulmonary dysplasia-associated pulmonary hypertension","volume":"6","author":"Backes","year":"2016","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib114","doi-asserted-by":"crossref","first-page":"L1073","DOI":"10.1152\/ajplung.00347.2006","article-title":"Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia","volume":"292","author":"Balasubramaniam","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.clp.2019.02.011_bib115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/2045-8932.97603","article-title":"Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension","volume":"2","author":"Hansmann","year":"2012","journal-title":"Pulm Circ"},{"issue":"6","key":"10.1016\/j.clp.2019.02.011_bib116","doi-asserted-by":"crossref","first-page":"F583","DOI":"10.1136\/archdischild-2017-314451","article-title":"Stem cell-based therapies in neonatology: a new hope","volume":"103","author":"Thebaud","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.clp.2019.02.011_bib117","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","article-title":"Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial","volume":"164","author":"Chang","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib118","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpeds.2017.02.061","article-title":"Two-Year Follow-up outcomes of premature infants enrolled in the phase I trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia","volume":"185","author":"Ahn","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib119","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/sctm.18-0079","article-title":"First-in-human administration of allogeneic amnion cells in premature infants with bronchopulmonary dysplasia: a safety study","volume":"7","author":"Lim","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.clp.2019.02.011_bib120","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstrom","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2019.02.011_bib121","article-title":"rhIGF-1\/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial","author":"Ley","year":"2018","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib122","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1933719108329095","article-title":"Inflammation and pregnancy","volume":"16","author":"Challis","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.clp.2019.02.011_bib123","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJMcibr1100071","article-title":"How does progesterone relax the uterus in pregnancy?","volume":"364","author":"Zakar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2019.02.011_bib124","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/molehr\/7.9.875","article-title":"Interactions between progesterone receptor isoforms in myometrial cells in human labour","volume":"7","author":"Pieber","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.clp.2019.02.011_bib125","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.1995.03520290065031","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes","volume":"273","author":"NIH Consensus Panel","year":"1995","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.clp.2019.02.011_bib126","first-page":"CD003063","article-title":"Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome","author":"Stevens","year":"2007","journal-title":"Cocharne Database Syst Rev"},{"key":"10.1016\/j.clp.2019.02.011_bib127","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s00431-016-2789-4","article-title":"Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis","volume":"175","author":"Rigo","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clp.2019.02.011_bib128","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJM199906243402505","article-title":"Vitamin A supplementation for extremely-low-birth-weight infants","volume":"340","author":"Tyson","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2019.02.011_bib129","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1164\/ajrccm\/142.5.1137","article-title":"Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia","volume":"142","author":"Brundage","year":"1990","journal-title":"Am Rev Respir Dis"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510819300223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510819300223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:56:53Z","timestamp":1758815813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510819300223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":129,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0095510819300223"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2019.02.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735581272.793576206","asserted-by":"object"}]},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2019.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}